SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-179359
Filing Date
2015-05-08
Accepted
2015-05-08 15:07:20
Documents
14
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d896578d10q.htm 10-Q 733811
2 EX-10.1 d896578dex101.htm EX-10.1 12989
3 EX-10.2 d896578dex102.htm EX-10.2 55571
4 EX-31.1 d896578dex311.htm EX-31.1 7160
5 EX-31.2 d896578dex312.htm EX-31.2 7221
6 EX-32.1 d896578dex321.htm EX-32.1 3864
7 EX-32.2 d896578dex322.htm EX-32.2 3925
14 GRAPHIC g896578g61q59.jpg GRAPHIC 6851
  Complete submission text file 0001193125-15-179359.txt   4845882

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT aegr-20150331.xml EX-101.INS 522993
9 XBRL TAXONOMY EXTENSION SCHEMA aegr-20150331.xsd EX-101.SCH 41805
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aegr-20150331_cal.xml EX-101.CAL 73956
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aegr-20150331_def.xml EX-101.DEF 131229
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE aegr-20150331_lab.xml EX-101.LAB 357722
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aegr-20150331_pre.xml EX-101.PRE 265186
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34921 | Film No.: 15846236
SIC: 2834 Pharmaceutical Preparations